Literature DB >> 20156555

Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic.

Alexandr Nemec1, Lenka Krizova, Martina Maixnerova, Martin Musilek.   

Abstract

To determine whether the high proportion of antimicrobial resistance among hospital isolates of Pseudomonas aeruginosa in the Czech Republic is associated with the spread of multidrug-resistant clones, we investigated 108 bloodstream isolates collected prospectively in 2007. The isolates originated from 48 hospitals in 36 cities and were serotyped, tested for susceptibility to 10 anti-Pseudomonas agents and studied by multilocus sequence typing, macrorestriction analysis and class 1 integron typing. Forty-five isolates were fully susceptible, while 14 and 49 isolates were resistant to 1-2 and 3-9 agents, respectively. A total of 42 multilocus sequence types (ST) were identified, of which ST235 (serotype O11), ST175 (O4) and ST132 (O6) included 19, 16 and 5 isolates, respectively. These three STs encompassed 40 (82%) of 49 isolates resistant to more than two agents and originated from 29 hospitals in 22 cities. Isolates of the same ST had highly similar macrorestriction patterns. Twelve ST235 isolates harbored an integron variable region with the gene cassette array of aacA7-aadA6-orfD, while 15 ST175 isolates shared a region with the aadB-aadA13 array and all ST132 isolates carried a region with aacA4. A carbapenemase-encoding gene (bla(IMP-7)) was detected in a single strain (ST357). In conclusion, the multidrug resistance of Czech P. aeruginosa bloodstream isolates in 2007 was predominantly associated with three epidemic clones, one of which belongs to international clonal complex CC235.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156555     DOI: 10.1016/j.resmic.2010.02.002

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  19 in total

1.  Spread of multidrug-resistant Pseudomonas aeruginosa clones in a university hospital.

Authors:  Maria Koutsogiannou; Eleanna Drougka; Apostolos Liakopoulos; Eleni Jelastopulu; Efthimia Petinaki; Evangelos D Anastassiou; Iris Spiliopoulou; Myrto Christofidou
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

2.  Biofilm formation, antibiotic susceptibility and RAPD genotypes in Pseudomonas aeruginosa clinical strains isolated from single centre intensive care unit patients.

Authors:  Martina Vaněrková; Barbora Mališová; Iva Kotásková; Veronika Holá; Filip Růžička; Tomáš Freiberger
Journal:  Folia Microbiol (Praha)       Date:  2017-04-01       Impact factor: 2.099

3.  Identification of VIM-2-producing Pseudomonas aeruginosa from Tanzania is associated with sequence types 244 and 640 and the location of blaVIM-2 in a TniC integron.

Authors:  Sabrina Moyo; Bjørg Haldorsen; Said Aboud; Bjørn Blomberg; Samuel Y Maselle; Arnfinn Sundsfjord; Nina Langeland; Ørjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

4.  Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.

Authors:  Alba Bellés; Jessica Bueno; Beatriz Rojo-Bezares; Carmen Torres; F Javier Castillo; Yolanda Sáenz; Cristina Seral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-06       Impact factor: 3.267

5.  Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis.

Authors:  Timothy J Kidd; Keith Grimwood; Kay A Ramsay; Paul B Rainey; Scott C Bell
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

6.  Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals.

Authors:  María García-Castillo; Rosa Del Campo; María Isabel Morosini; Elena Riera; Gabriel Cabot; Rob Willems; Rosa van Mansfeld; Antonio Oliver; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

7.  Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types.

Authors:  Pascal Cholley; Michelle Thouverez; Didier Hocquet; Nathalie van der Mee-Marquet; Daniel Talon; Xavier Bertrand
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

8.  Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.

Authors:  Costas C Papagiannitsis; Matej Medvecky; Katerina Chudejova; Anna Skalova; Veronika Rotova; Petra Spanelova; Vladislav Jakubu; Helena Zemlickova; Jaroslav Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

Review 9.  Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.

Authors:  Theodoros Karampatakis; Charalampos Antachopoulos; Athanassios Tsakris; Emmanuel Roilides
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-11       Impact factor: 3.267

10.  Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio.

Authors:  Federico Perez; Andrea M Hujer; Steven H Marshall; Amy J Ray; Philip N Rather; Nuntra Suwantarat; Donald Dumford; Patrick O'Shea; T Nicholas J Domitrovic; Robert A Salata; Kalyan D Chavda; Liang Chen; Barry N Kreiswirth; Alejandro J Vila; Susanne Haussler; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.